BCLI
Price
$1.22
Change
+$0.09 (+7.96%)
Updated
Jun 6 closing price
Capitalization
8.93M
TBPH
Price
$11.25
Change
+$0.48 (+4.46%)
Updated
Jun 6 closing price
Capitalization
539.01M
63 days until earnings call
Interact to see
Advertisement

BCLI vs TBPH

Header iconBCLI vs TBPH Comparison
Open Charts BCLI vs TBPHBanner chart's image
Brainstorm Cell Therapeutics
Price$1.22
Change+$0.09 (+7.96%)
Volume$518.95K
Capitalization8.93M
Theravance Biopharma
Price$11.25
Change+$0.48 (+4.46%)
Volume$295.02K
Capitalization539.01M
BCLI vs TBPH Comparison Chart
Loading...
BCLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TBPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCLI vs. TBPH commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCLI is a StrongBuy and TBPH is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (BCLI: $1.06 vs. TBPH: $9.15)
Brand notoriety: BCLI and TBPH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCLI: 13% vs. TBPH: 62%
Market capitalization -- BCLI: $8.93M vs. TBPH: $539.01M
BCLI [@Biotechnology] is valued at $8.93M. TBPH’s [@Biotechnology] market capitalization is $539.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCLI’s FA Score shows that 0 FA rating(s) are green whileTBPH’s FA Score has 0 green FA rating(s).

  • BCLI’s FA Score: 0 green, 5 red.
  • TBPH’s FA Score: 0 green, 5 red.
According to our system of comparison, TBPH is a better buy in the long-term than BCLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCLI’s TA Score shows that 4 TA indicator(s) are bullish while TBPH’s TA Score has 5 bullish TA indicator(s).

  • BCLI’s TA Score: 4 bullish, 5 bearish.
  • TBPH’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, TBPH is a better buy in the short-term than BCLI.

Price Growth

BCLI (@Biotechnology) experienced а -10.17% price change this week, while TBPH (@Biotechnology) price change was -2.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

TBPH is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TBPH($539M) has a higher market cap than BCLI($8.93M). TBPH YTD gains are higher at: -2.763 vs. BCLI (-53.304). BCLI has higher annual earnings (EBITDA): -13.06M vs. TBPH (-38.45M). TBPH has more cash in the bank: 88.4M vs. BCLI (168K). BCLI has less debt than TBPH: BCLI (841K) vs TBPH (49.8M). TBPH has higher revenues than BCLI: TBPH (64.4M) vs BCLI (0).
BCLITBPHBCLI / TBPH
Capitalization8.93M539M2%
EBITDA-13.06M-38.45M34%
Gain YTD-53.304-2.7631,929%
P/E RatioN/AN/A-
Revenue064.4M-
Total Cash168K88.4M0%
Total Debt841K49.8M2%
FUNDAMENTALS RATINGS
BCLI vs TBPH: Fundamental Ratings
BCLI
TBPH
OUTLOOK RATING
1..100
925
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
39
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10096
PRICE GROWTH RATING
1..100
6556
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TBPH's Valuation (39) in the Pharmaceuticals Other industry is somewhat better than the same rating for BCLI (89) in the Computer Peripherals industry. This means that TBPH’s stock grew somewhat faster than BCLI’s over the last 12 months.

TBPH's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as BCLI (100) in the Computer Peripherals industry. This means that TBPH’s stock grew similarly to BCLI’s over the last 12 months.

TBPH's SMR Rating (96) in the Pharmaceuticals Other industry is in the same range as BCLI (100) in the Computer Peripherals industry. This means that TBPH’s stock grew similarly to BCLI’s over the last 12 months.

TBPH's Price Growth Rating (56) in the Pharmaceuticals Other industry is in the same range as BCLI (65) in the Computer Peripherals industry. This means that TBPH’s stock grew similarly to BCLI’s over the last 12 months.

TBPH's P/E Growth Rating (100) in the Pharmaceuticals Other industry is in the same range as BCLI (100) in the Computer Peripherals industry. This means that TBPH’s stock grew similarly to BCLI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BCLITBPH
RSI
ODDS (%)
N/A
Bullish Trend 12 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 12 days ago
90%
Bearish Trend 12 days ago
84%
Momentum
ODDS (%)
Bearish Trend 12 days ago
88%
Bullish Trend 12 days ago
82%
MACD
ODDS (%)
Bearish Trend 12 days ago
88%
Bearish Trend 12 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
70%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
82%
Bearish Trend 12 days ago
71%
Advances
ODDS (%)
Bullish Trend 21 days ago
83%
Bullish Trend 20 days ago
72%
Declines
ODDS (%)
Bearish Trend 18 days ago
89%
Bearish Trend 12 days ago
74%
BollingerBands
ODDS (%)
Bearish Trend 12 days ago
89%
Bullish Trend 12 days ago
79%
Aroon
ODDS (%)
Bullish Trend 12 days ago
66%
Bullish Trend 12 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
BCLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TBPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

BCLI and

Correlation & Price change

A.I.dvisor tells us that BCLI and ATHE have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BCLI and ATHE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCLI
1D Price
Change %
BCLI100%
-1.85%
ATHE - BCLI
27%
Poorly correlated
+1.64%
LABFF - BCLI
26%
Poorly correlated
N/A
KOD - BCLI
24%
Poorly correlated
-2.23%
TBPH - BCLI
24%
Poorly correlated
-1.40%
MTNB - BCLI
24%
Poorly correlated
+6.25%
More

TBPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, TBPH has been loosely correlated with ELEV. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if TBPH jumps, then ELEV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TBPH
1D Price
Change %
TBPH100%
-1.40%
ELEV - TBPH
40%
Loosely correlated
-0.98%
IMCR - TBPH
31%
Poorly correlated
-1.72%
ARCT - TBPH
31%
Poorly correlated
-1.75%
INZY - TBPH
29%
Poorly correlated
N/A
AUTL - TBPH
29%
Poorly correlated
+5.10%
More